HPM Partners »

Maxcyte shares owned by HPM Partners

Quarter-by-quarter ownership of Maxcyte (MXCT) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Maxcyte

Tip: Access up to 7 years of quarterly data

All positions including Maxcyte held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maxcyte by HPM Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $32k 46k 0.70
2025-09-30 $49k 31k 1.58
2023-06-30 $58k 13k 4.61

More positions owned by HPM Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Procter & Gamble Company (PG)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Msci Usa Qlt Fct (QUAL)

View all positions for HPM Partners

Top funds holding Maxcyte

BlackRock
Capricorn Fund Managers
Vanguard Group
Vitruvian Partners
Vanguard Capital Management
Morgan Stanley
Mudita Advisors
Bnp Paribas Investment Partners
Geode Capital Management
State Street Corporation
Cadian Capital Management
Peapod Lane Capital
AQR Capital Management
Goldman Sachs Group
Luminus Management

View all funds holding Maxcyte